A cancer drug class best known for attacking tumors may also help your immune system remember them better. Researchers at ...

No other school kicks off a reading program like Forestville does. Each year, Forestville holds a celebration for its annual Pick a Reading Partner (PARP) program. A team of teachers and staff come ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in breast cancer patients can interact and drive resistance to certain drugs ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in breast cancer patients ...

In the real-world, Pluvicto™ showed 13.5 months median PFS in chemo-naïve patients with PSMA-positive mCRPC; Real‑world evidence showed Pluvicto achieved longer PFS when init ...

Dr Martin brings over two decades of leadership in translational science, drug discovery and biotech strategy and entrepreneurshipStrengthens Link’s position as it advances its proprietary TSG-6-based ...

Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the risk of progression or death, with an early trend toward improved overall ...

The Prostate Cancer Foundation (PCF) today announced the recipients of its 2025 Challenge Awards, providing over $12 million in funding for 12 multi-institutional, cross-disciplinary research teams ...

The future will be all about anti-aging medicine as people want to spend a longer time living healthily and a shorter time dying.

Shreyas Sen is the Founder and CTO of Quasistatics, Inc. (dba Ixana), which develops Wi-R, a wireless body-area communication technology. He owns shares in the company. How do headphones, toys, ...